James River Group Holdings (JRVR) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual General Meeting scheduled for October 23, 2025, with proxy materials distributed starting September 17, 2025.
Key business actions include director elections, auditor re-appointment, executive compensation approval, and amendments to incentive plans.
Shareholders can vote in person, by mail, phone, or online; record date is September 3, 2025.
Voting matters and shareholder proposals
Election of eight directors for a one-year term until the 2026 meeting.
Re-appointment of Ernst & Young LLP as independent auditor and authorization for remuneration.
Advisory vote on 2024 executive compensation (say-on-pay).
Amendments to the 2014 Long-Term Incentive Plan and 2014 Non-Employee Director Incentive Plan to increase authorized shares.
Board recommends voting FOR all proposals.
Board of directors and corporate governance
Eight nominees, including a mix of experienced executives and industry experts, with 50% having 0-2 years tenure and 62.5% aged 61+.
Board committees: Audit, Compensation and Human Capital, Nominating and Corporate Governance, and Investment.
All directors except the CEO are independent; one director designated by a major shareholder under an investment agreement.
Annual board and committee self-evaluations; robust code of conduct and governance guidelines.
Latest events from James River Group Holdings
- 2025 marked a sharp turnaround to profitability, capital growth, and E&S-driven operational gains.JRVR
Q4 202527 Mar 2026 - Earnings rose on investment gains and strategic actions, but reserve and legal risks persist.JRVR
Q2 20242 Feb 2026 - Q3 2024 net loss of $40.7M driven by reserve charges, reinsurance, and strategic capital actions.JRVR
Q3 202415 Jan 2026 - Over 21 million common shares registered for resale by major investors, with no proceeds to the company.JRVR
Registration Filing16 Dec 2025 - Q4 2024 net loss of $92.7M; E&S premiums top $1B; 2025 outlook positive.JRVR
Q4 202416 Dec 2025 - Annual Meeting to vote on directors, auditor, compensation, and incentive plan amendments.JRVR
Proxy Filing2 Dec 2025 - Q1 net income dropped to $9M as E&S pricing rose and Specialty Admitted premiums declined.JRVR
Q1 202524 Nov 2025 - Q2 2025 saw $11.7M adjusted net income, 14% return, and record E&S premiums amid strategic changes.JRVR
Q2 202523 Nov 2025 - Strong underwriting and cost discipline drove a 19.3% return and 94% combined ratio.JRVR
Q3 202514 Nov 2025